Cargando…
Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: Randomized, double-blind, placebo-controlled Phase I studies
We report the findings of three randomized, double-blind, placebo-controlled Phase I studies undertaken to support licensure of the liquid formulation of the human G1P[8] rotavirus (RV) vaccine (RIX4414; GlaxoSmithKline Biologicals SA) in China. Healthy adults aged 18–45 y (n = 48) and children aged...
Autores principales: | Li, Rong-Cheng, Li, Yan-Ping, Mo, Zhao-Jun, Luo, Dong, Huang, Teng, Kong, Ji-Lian, Wang, Lao-Hong, Song, Ning-Sheng, Liu, Aixue, Zhang, Helen, Liao, Xueyan, Karkada, Naveen, Han, Htay Htay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906260/ https://www.ncbi.nlm.nih.gov/pubmed/23807360 http://dx.doi.org/10.4161/hv.25076 |
Ejemplares similares
-
Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants
por: Li, Rong-cheng, et al.
Publicado: (2015) -
Post-marketing safety surveillance conducted in Korea (2008–2013) following the introduction of the rotavirus vaccine, RIX4414 (Rotarix™)
por: Shin, Son Moon, et al.
Publicado: (2016) -
Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: A randomized, placebo-controlled trial in China
por: Li, Rong-cheng, et al.
Publicado: (2014) -
Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414
por: Cunliffe, Nigel, et al.
Publicado: (2014) -
The human rotavirus vaccine Rotarix™ in infants: An integrated analysis of safety and reactogenicity
por: Buyse, Hubert, et al.
Publicado: (2014)